JP2003523397A5 - - Google Patents

Download PDF

Info

Publication number
JP2003523397A5
JP2003523397A5 JP2001561333A JP2001561333A JP2003523397A5 JP 2003523397 A5 JP2003523397 A5 JP 2003523397A5 JP 2001561333 A JP2001561333 A JP 2001561333A JP 2001561333 A JP2001561333 A JP 2001561333A JP 2003523397 A5 JP2003523397 A5 JP 2003523397A5
Authority
JP
Japan
Prior art keywords
composition
solvent
mixture
beauty
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001561333A
Other languages
English (en)
Japanese (ja)
Other versions
JP5596249B2 (ja
JP2003523397A (ja
Filing date
Publication date
Priority claimed from DE10008128A external-priority patent/DE10008128A1/de
Application filed filed Critical
Publication of JP2003523397A publication Critical patent/JP2003523397A/ja
Publication of JP2003523397A5 publication Critical patent/JP2003523397A5/ja
Application granted granted Critical
Publication of JP5596249B2 publication Critical patent/JP5596249B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2001561333A 2000-02-22 2001-02-09 殺内部寄生虫剤 Expired - Lifetime JP5596249B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10008128.2 2000-02-22
DE10008128A DE10008128A1 (de) 2000-02-22 2000-02-22 Endoparasitizide Mittel
PCT/EP2001/001392 WO2001062268A1 (de) 2000-02-22 2001-02-09 Endoparasitizide mittel

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012006256A Division JP2012107024A (ja) 2000-02-22 2012-01-16 殺内部寄生虫剤

Publications (3)

Publication Number Publication Date
JP2003523397A JP2003523397A (ja) 2003-08-05
JP2003523397A5 true JP2003523397A5 (OSRAM) 2008-03-13
JP5596249B2 JP5596249B2 (ja) 2014-09-24

Family

ID=7631886

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001561333A Expired - Lifetime JP5596249B2 (ja) 2000-02-22 2001-02-09 殺内部寄生虫剤
JP2012006256A Pending JP2012107024A (ja) 2000-02-22 2012-01-16 殺内部寄生虫剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012006256A Pending JP2012107024A (ja) 2000-02-22 2012-01-16 殺内部寄生虫剤

Country Status (25)

Country Link
US (1) US20030125244A1 (OSRAM)
EP (1) EP1259250B1 (OSRAM)
JP (2) JP5596249B2 (OSRAM)
KR (1) KR100755414B1 (OSRAM)
CN (1) CN1309415C (OSRAM)
AR (2) AR028218A1 (OSRAM)
AT (1) ATE343394T1 (OSRAM)
AU (2) AU4060501A (OSRAM)
BR (1) BR0108562B1 (OSRAM)
CA (1) CA2400610C (OSRAM)
CZ (1) CZ300242B6 (OSRAM)
DE (2) DE10008128A1 (OSRAM)
DK (1) DK1259250T3 (OSRAM)
ES (1) ES2274871T3 (OSRAM)
HK (1) HK1054326B (OSRAM)
HU (1) HUP0204554A3 (OSRAM)
IL (2) IL150988A0 (OSRAM)
MX (1) MXPA02008210A (OSRAM)
NO (1) NO328949B1 (OSRAM)
NZ (1) NZ520856A (OSRAM)
PL (1) PL203999B1 (OSRAM)
PT (1) PT1259250E (OSRAM)
RU (1) RU2292905C2 (OSRAM)
WO (1) WO2001062268A1 (OSRAM)
ZA (1) ZA200205982B (OSRAM)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10104362A1 (de) * 2001-02-01 2002-08-08 Bayer Ag Kristallmodifikation eines cyclischen Depsipeptids mit besserer Wirksamkeit
EP1561820B1 (en) * 2002-11-12 2008-12-31 The Kitasato Institute Anthelmintic substance fki-1033 and process for producing the same
DE10358525A1 (de) 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
MX2011002166A (es) 2008-08-28 2011-04-07 Pfizer Derivados de dioxa-biciclo[3.2.1]octano-2,3,1-triol.
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
HRP20211041T1 (hr) 2015-05-20 2021-10-01 Boehringer Ingelheim Animal Health USA Inc. Anthelmintski depsipeptidni spojevi
RU2715556C2 (ru) 2015-12-28 2020-03-02 Мериал, Инк. Противогельминтные депсипептидные соединения
JP2020504710A (ja) 2016-11-16 2020-02-13 ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド 駆虫性デプシペプチド化合物
EP4013388A1 (en) 2019-08-14 2022-06-22 Vetoquinol SA Compositions comprising tigolaner for controlling parasites

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3531545A1 (de) * 1985-09-04 1987-03-05 Goedecke Ag Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung
DE3705227A1 (de) * 1987-02-19 1988-09-01 Bayer Ag Anthelminthische wirkstoffkombinationen
DE69331414T2 (de) * 1992-03-17 2002-08-08 Fujisawa Pharmaceutical Co., Ltd. Depsipeptide, herstellung und anwendung
DE4317458A1 (de) * 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4309830C1 (de) * 1993-03-26 1994-05-05 Lohmann Therapie Syst Lts Wirkstoffpflaster für die Abgabe von Estradiol an die Haut
DE4317457A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) * 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
WO1995021624A1 (en) * 1994-02-08 1995-08-17 Nippon Kayaku Kabushiki Kaisha High-concentration aureobasidin preparation in solution form
DE4417742A1 (de) * 1994-05-20 1995-11-23 Bayer Ag Nicht-systemische Bekämpfung von Parasiten
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
DE19545044A1 (de) * 1995-12-02 1997-06-05 Bayer Ag Endoparasitizide Mittel
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
JP4098474B2 (ja) * 1998-03-19 2008-06-11 メルク エンド カムパニー インコーポレーテッド 外部寄生虫侵入防除用硫黄ペンタフルオロフェニルピラゾール
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel

Similar Documents

Publication Publication Date Title
JP2002542199A5 (OSRAM)
EP1138314A3 (en) Controlled delivery system of antifungal and keratolytic agents for local treatment of fungal infections of the nail and surrounding tissues
BR0107869A (pt) Composições farmacêuticas eletrogiradas
WO2004043363A8 (en) Protein-stabilized liposomal formulations of pharmaceutical agents
NZ511201A (en) Use of paclitaxel stabilized with albumin for preparing a drug for the treatment of solid tumors and the drug obtained thereby
WO2002017918A3 (en) Sustained release formulations for growth hormone secretagogues
EA200400471A1 (ru) Оральная дозированная форма пропиверина
CA2404810A1 (en) Topical composition having undifferentiated plant seed cells and method for using same
CA2402791A1 (en) Pre-formed sheet devices for topical application comprising a benefit agent coated solid gel sheet
WO2004071538A3 (en) Topical delivery of cosmetic agents
PT1089704E (pt) Locao tricologica para aplicacao topica
FR2810883B1 (fr) Nouveaux latex inverses autoinversibles sur des esters d'acides gras, compositions cosmetiques, dermocosmetiques, dermopharmaceutiques ou pharmaceutiques en comportant
JP2003523397A5 (OSRAM)
MXPA05004537A (es) Formulaciones conteniendo melatonina, ginkgo biloba y biotina.
WO2002030467A3 (en) Pharmaceutical composition containing honey for the treatment of wounds
ATE322878T1 (de) Biotin enthaltende galenische formulierung
CA2571796A1 (en) Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
WO2003066597A3 (en) Guanidino compounds
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
JP2002542281A5 (OSRAM)
JP2002537232A5 (OSRAM)
ES2181592B1 (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas
AU2002328873A1 (en) Dosage forms comprising particles containing active ingredient for application on the skin or mucous membrane
WO2006088945A3 (en) Granulysin peptides and methods of use thereof
WO2001085188A3 (en) Use of echinacea as a hematinic agent